Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry
- 1 April 2014
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (4) , 354-361
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
- Abbott Vascular
- Bristol-Myers Squibb
- Medicines Company
This publication has 16 references indexed in Scilit:
- Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trialThe Lancet, 2013
- Drug-Eluting Stent for Left Main Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionJACC, 2011
- Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery DiseaseJACC, 2010
- Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive CardiologyEuropean Heart Journal, 2009
- Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registryEuropean Heart Journal, 2009
- Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery DiseaseNew England Journal of Medicine, 2008
- Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary ArteryCirculation, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent EraJACC, 2006